Cargando…
Toxic anterior segment syndrome following trabeculectomy with mitomycin C
OBJECTIVE: Toxic anterior segment (TASS) is a rare acute sterile anterior segment inflammation that typically develops within 12 to 24 hours after an anterior segment surgery. The purpose of this case report is to alert surgeons to the possibility of this complication following any anterior segment...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
German Medical Science GMS Publishing House
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577659/ https://www.ncbi.nlm.nih.gov/pubmed/37850220 http://dx.doi.org/10.3205/oc000225 |
_version_ | 1785121372806053888 |
---|---|
author | Ginger-Eke, Helen Ogbonnaya, Chimdia Odayappan, Annamalai Shiweobi, Jude |
author_facet | Ginger-Eke, Helen Ogbonnaya, Chimdia Odayappan, Annamalai Shiweobi, Jude |
author_sort | Ginger-Eke, Helen |
collection | PubMed |
description | OBJECTIVE: Toxic anterior segment (TASS) is a rare acute sterile anterior segment inflammation that typically develops within 12 to 24 hours after an anterior segment surgery. The purpose of this case report is to alert surgeons to the possibility of this complication following any anterior segment surgery, including trabeculectomy, and to highlight the possible etiologies and measures to prevent it. PATIENT AND METHOD: A 58-year-old male glaucoma patient was initially managed medically for primary open angle glaucoma with antiglaucoma medications. There was rapidly progressive glaucomatous optic nerve damage in his left eye within the following year, despite the use of antiglaucoma medications, hence the need for trabeculectomy. RESULT: The post-operative condition of the patient’s eye was stormy with diffuse limbus-to-limbus corneal edema and profound Descemet’s membrane folds, among other features of TASS, with associated deteriorating visual acuity. CONCLUSION: Although there is no documented report of TASS following trabeculectomy with mitomycin C, surgeons should be alerted to this possibility. Preventive measures include extreme care to avoid errors while preparing and administering diluted solutions, especially medications that are administered into the intracameral space. |
format | Online Article Text |
id | pubmed-10577659 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | German Medical Science GMS Publishing House |
record_format | MEDLINE/PubMed |
spelling | pubmed-105776592023-10-17 Toxic anterior segment syndrome following trabeculectomy with mitomycin C Ginger-Eke, Helen Ogbonnaya, Chimdia Odayappan, Annamalai Shiweobi, Jude GMS Ophthalmol Cases Article OBJECTIVE: Toxic anterior segment (TASS) is a rare acute sterile anterior segment inflammation that typically develops within 12 to 24 hours after an anterior segment surgery. The purpose of this case report is to alert surgeons to the possibility of this complication following any anterior segment surgery, including trabeculectomy, and to highlight the possible etiologies and measures to prevent it. PATIENT AND METHOD: A 58-year-old male glaucoma patient was initially managed medically for primary open angle glaucoma with antiglaucoma medications. There was rapidly progressive glaucomatous optic nerve damage in his left eye within the following year, despite the use of antiglaucoma medications, hence the need for trabeculectomy. RESULT: The post-operative condition of the patient’s eye was stormy with diffuse limbus-to-limbus corneal edema and profound Descemet’s membrane folds, among other features of TASS, with associated deteriorating visual acuity. CONCLUSION: Although there is no documented report of TASS following trabeculectomy with mitomycin C, surgeons should be alerted to this possibility. Preventive measures include extreme care to avoid errors while preparing and administering diluted solutions, especially medications that are administered into the intracameral space. German Medical Science GMS Publishing House 2023-09-29 /pmc/articles/PMC10577659/ /pubmed/37850220 http://dx.doi.org/10.3205/oc000225 Text en Copyright © 2023 Ginger-Eke et al. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Ginger-Eke, Helen Ogbonnaya, Chimdia Odayappan, Annamalai Shiweobi, Jude Toxic anterior segment syndrome following trabeculectomy with mitomycin C |
title | Toxic anterior segment syndrome following trabeculectomy with mitomycin C |
title_full | Toxic anterior segment syndrome following trabeculectomy with mitomycin C |
title_fullStr | Toxic anterior segment syndrome following trabeculectomy with mitomycin C |
title_full_unstemmed | Toxic anterior segment syndrome following trabeculectomy with mitomycin C |
title_short | Toxic anterior segment syndrome following trabeculectomy with mitomycin C |
title_sort | toxic anterior segment syndrome following trabeculectomy with mitomycin c |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577659/ https://www.ncbi.nlm.nih.gov/pubmed/37850220 http://dx.doi.org/10.3205/oc000225 |
work_keys_str_mv | AT gingerekehelen toxicanteriorsegmentsyndromefollowingtrabeculectomywithmitomycinc AT ogbonnayachimdia toxicanteriorsegmentsyndromefollowingtrabeculectomywithmitomycinc AT odayappanannamalai toxicanteriorsegmentsyndromefollowingtrabeculectomywithmitomycinc AT shiweobijude toxicanteriorsegmentsyndromefollowingtrabeculectomywithmitomycinc |